Artificial Urethra Market To Reach USD 841.44 Million by 2026 | Reports And Data
/
Date01 Oct 2019
Email Print Friendly Share New York, Sept. 30, 2019 (GLOBE NEWSWIRE) — According to the current analysis of Reports and Data, the Global Artificial urethra... Read More →
Itafos Announces Amendment to Credit and Guaranty Agreement
/
Date01 Oct 2019
Email Print Friendly Share TORONTO, Sept. 30, 2019 (GLOBE NEWSWIRE) — Itafos (TSX VENTURE: IFOS) (the “Company”) announced today that it has executed an amendment... Read More →
1st Capital Bank Announces Declaration of 7.00% Stock Dividend
/
Date01 Oct 2019
Email Print Friendly Share SALINAS, Calif., Sept. 30, 2019 (GLOBE NEWSWIRE) — 1st Capital Bank (OTC Pink: FISB) today announced the Bank’s board of directors... Read More →
Predictive Technology Group Reports Fiscal Year 2019 Financial Results
/
Date01 Oct 2019
Email Print Friendly Share SALT LAKE CITY, Sept. 30, 2019 (GLOBE NEWSWIRE) — Predictive Technology Group, Inc. (OTC PINK: PRED) (the Company), a leader in... Read More →
Glacier Bancorp, Inc. to Acquire State Bank Corp.
/
Date01 Oct 2019
Email Print Friendly Share LAKE HAVASU CITY, Ariz., Sept. 30, 2019 (GLOBE NEWSWIRE) — State Bank Corp., the Lake Havasu City-based holding company for State... Read More →
Molina Healthcare Announces Third Quarter 2019 Earnings Release and Conference Call Dates
/
Date01 Oct 2019
Email Print Friendly Share Long Beach, Calif., Sept. 30, 2019 (GLOBE NEWSWIRE) — Molina Healthcare, Inc. (NYSE: MOH) today announced details for the release of... Read More →
Solutions 30 : 2019 Half-Year Financial Report
/
Date01 Oct 2019
Email Print Friendly Share 2019 Half-Year Financial Report SOLUTIONS 30 has posted its 2019 Half-Year financial report. This report is available for consultation and... Read More →
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in China
/
Date01 Oct 2019
Email Print Friendly Share LA JOLLA, Calif., Sept. 30, 2019 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the... Read More →
ADC Therapeutics kündigt den Start des Börsengangs an
/
Date01 Oct 2019
Email Print Friendly Share LAUSANNE, Schweiz, Sept. 24, 2019 (GLOBE NEWSWIRE) — ADC Therapeutics SA, ein auf die klinische Phase der Onkologie fokussiertes Biotechnologieunternehmen, das... Read More →